Careers Header Bg
Regask Raps
REGASK SPONSORS

RAPS Euro Convergence 2025

MAY 13-16, 2025  |  BRUSSELS, BELGIUM

Square Brussels Convention Centre, Booth No.3

Meet us at RAPS Euro Convergence 2025!

Meet our team

Join, Yasmine Fathallah, and Ilkka Howard at the RegASK booth to explore how our AI-driven regulatory intelligence is transforming compliance strategies.

Learn more with them about –

  • The game-changing role of AI in revolutionizing regulatory intelligence
  • How RegASK’s cutting-edge technology is streamlining regulatory workflows
  • How our AI-driven solutions can empower your organization to stay ahead of evolving global regulations.
Raps Euro Convergence Attendees V2

Yasmine Fathallah

Client Solution Manager

Ilkka Howard

Business Development Account Director



Bg Flip Card 1

RAPS Euro Convergence 2025

RAPS Euro Convergence is the most comprehensive regulatory affairs conference in Europe, focusing on the latest topics and developments in healthcare products in Europe and beyond — with sessions in medical devices, IVDs, pharmaceuticals, combination products, regulatory business, AI, software, and cybersecurity.

RAPS Euro Convergence unites regulatory affairs professionals and industry partners to share and collaborate on solutions for the improvement and advancement of healthcare in Europe.

Reasons to Attend

  • Access curated content by EU senior regulatory experts and notable health authorities.
  • Connect with EU and global solution providers on the latest innovations.
  • Experience comprehensive insights, perspectives, and exchanges with global leaders to accelerate actionable, intelligent roadmaps for your organisation.

RAPS Euro Convergence 2025 Programme

RAPS Euro Convergence provides essential knowledge in the medical device, IVD, and pharmaceutical industries, which will prepare you to successfully navigate the EU regulatory landscape.

Transforming the European regulatory environment through collaborative innovation

The European regulatory affairs profession has made great strides within the European healthcare industry. With so much progress, how can Europe maintain its global position and competitiveness for the years to come? The regulatory affairs community will gather in Brussels, Belgium, from 13 to 16 May for in-depth learning and discussions, focusing on innovation, sustainability, resiliency, and dynamic transformation, all to position the European region as a leading region in healthcare regulations.

Meet us at RAPS Euro Convergence 2025!

Our solution

RegASK leverages advanced AI and machine learning to help businesses in highly regulated industries streamline their regulatory compliance processes and stay ahead of the curve. Our cutting-edge solution automates regulatory research, provides vital insights, and empowers regulatory affairs teams to become strategic partners in driving business growth.

Resources

Navigating a Potential U.S. Government Shutdown: Implic…
As legislators in Washington, DC, face a critical March 14th deadline to finalize federal spending, the possibility of a U.S. government shu…
Read more
RegASK Featured in Gartner’s Market Guide for Regulat…
We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …
Read more
The 2025 State of Regulatory Affairs and Compliance Rep…
Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more complex than ever, with new adv…
Read more
ANSM (France) Clarifies CE Mark Exemption Process for M…
On January 27, 2025, the National Security Agency of Medicines and Health Products (ANSM) in France issued a key update regarding the proces…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Establishes New Center for Real-World Evidenc…
On December 12, 2024, the U.S. Food and Drug Administration (FDA) announced the creation of the Center for Real-World Evidence and Innovatio…
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more